Decent volume went through the market on Wednesday. CEZ and Zentiva were the most active names. Zentiva skyrocketed after Sanofi’s counterbid at CZK 1,050, the stock closed at its intraday some CZK 70 above this level. CEZ was actively traded between CZK 1,310 and CZK 1,325 level after maintaining Buy recommendation at Merrill Lynch with the increased target price of CZK 1,510 implying 15% upside. Continuing good international demand lifted NWR before PX Index inclusion. Price was also supported by initiation Buy coverage by Unicredit with target price set at CZK 656 per share which implies 16% upside. Banks were under pressure in-line with the global sentiment.